XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Capital Surplus [Member]
Capital Surplus [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Total Shareholders' Equity [Member]
Total Shareholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjustment
Total Shareholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Non-Controlling Interests [Member]
Non-Controlling Interests [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance, beginning of period (in shares) at Dec. 31, 2018       75,711 75,711           3,589 3,589              
Balance, beginning of period at Dec. 31, 2018 $ 4,443,045   $ 4,445,907 $ 5 $ 5 $ 1,334,030 $ 1,334,030 $ 3,369,654   $ 3,372,516 $ (198,995) $ (198,995) $ (72,585) $ (72,585) $ 4,432,109   $ 4,434,971 $ 10,936 $ 10,936
Balance, beginning of period (Accounting Standards Update 2016-02) at Dec. 31, 2018   $ 2,862             $ 2,862             $ 2,862      
Net income 500,685             500,758             500,758     (73)  
Other comprehensive income (loss), net 177,508                       177,508   177,508        
Repurchase of common stock (in shares)                     1,572                
Repurchase of common stock (129,483)                   $ (129,483)       (129,483)        
Stock options exercised (in shares)       27                              
Stock options exercised 1,421         1,421                 1,421        
Non-vested shares awarded, net (in shares)       21                              
Vesting of non-vested shares (in shares)                     18                
Vesting of non-vested shares (1,428)                   $ (1,428)       (1,428)        
Share-based compensation 15,544         15,544                 15,544        
Cash dividends on common stock (143,496)             (143,496)             (143,496)        
Capital calls and distributions, net 2,739                                 2,739  
Balance, end of period (in shares) at Dec. 31, 2019       75,759 75,759           5,179 5,179              
Balance, end of period at Dec. 31, 2019 4,863,919   4,817,223 $ 5 $ 5 1,350,995 1,350,995 3,729,778   3,683,082 $ (329,906) $ (329,906) 104,923 104,923 4,855,795   4,809,099 8,124 8,124
Balance, end of period (Accounting Standards Update 2016-13) at Dec. 31, 2019   $ (46,696)             $ (46,696)             $ (46,696)      
Net income 435,071             435,030             435,030     41  
Other comprehensive income (loss), net 230,945                       230,945   230,945        
Repurchase of common stock (in shares)                     1,107                
Repurchase of common stock (75,830)                   $ (75,830)       (75,830)        
Stock options exercised (in shares)       12                              
Stock options exercised 675         675                 675        
Non-vested shares awarded, net (in shares)       224                              
Vesting of non-vested shares (in shares)                     72                
Vesting of non-vested shares (5,608)                   $ (5,608)       (5,608)        
Share-based compensation 16,392         16,392                 16,392        
Cash dividends on common stock (144,437)             (144,437)             (144,437)        
Capital calls and distributions, net 17,130                                 17,130  
Balance, end of period (in shares) at Dec. 31, 2020       75,995 75,995           6,358 6,358              
Balance, end of period at Dec. 31, 2020 5,291,561   $ 5,291,561 $ 5 $ 5 1,368,062 $ 1,368,062 3,973,675   $ 3,973,675 $ (411,344) $ (411,344) 335,868 $ 335,868 5,266,266   $ 5,266,266 25,295 $ 25,295
Net income 616,325             618,121             618,121     (1,796)  
Other comprehensive income (loss), net (263,497)                       (263,497)   (263,497)        
Repurchase of common stock (in shares)                     1,360                
Repurchase of common stock (117,938)                   $ (117,938)       (117,938)        
Stock options exercised (in shares)       17                              
Stock options exercised 973         973                 973        
Non-vested shares awarded, net (in shares)       242                              
Vesting of non-vested shares (in shares)                     68                
Vesting of non-vested shares (5,847)                   $ (5,847)       (5,847)        
Share-based compensation 9,759         9,759                 9,759        
Cash dividends on common stock (144,105)             (144,105)             (144,105)        
Capital calls and distributions, net 18,860                                 18,860  
Balance, end of period (in shares) at Dec. 31, 2021       76,254             7,786                
Balance, end of period at Dec. 31, 2021 $ 5,368,371     $ 5   $ 1,378,794   $ 4,447,691     $ (535,129)   $ 72,371   $ 5,363,732     $ 4,639